LPL Financial
AMRX icon

LPL Financial’s Amneal Pharmaceuticals AMRX Stock Holding History

LPL Financial’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,000
Closed -$79.2K – 5351
2024
Q4 		$79.2K Buy
+10,000
New +$83.9K ﹤0.01% 5035

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

LPL Financial's AMRX Position: Q2 2026 in Review

LPL Financial increased its Amneal Pharmaceuticals (AMRX) stake by 27% in Q2 2026, buying an estimated $269K and bringing the position to 91,332 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #4001.

LPL Financial first reported a position in AMRX in Q3 2020 and has held it in 24 quarters since. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • LPL Financial held 91,332 shares of Amneal Pharmaceuticals worth $1.58M as of Q2 2026.
  • LPL Financial bought 19,643 Amneal Pharmaceuticals shares in Q2 2026, an estimated $269K.
  • Amneal Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4001 holding.
  • LPL Financial first reported a position in Amneal Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.